Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Day One Biopharmaceuticals stock

Learn how to easily invest in Day One Biopharmaceuticals stock.

Day One Biopharmaceuticals is a biotechnology business based in the US. Day One Biopharmaceuticals shares (DAWN) are listed on the NASDAQ and all prices are listed in US Dollars. Day One Biopharmaceuticals employs 125 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Day One Biopharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DAWN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Day One Biopharmaceuticals stock price (NASDAQ: DAWN)

Use our graph to track the performance of DAWN stocks over time.

Day One Biopharmaceuticals shares at a glance

Information last updated 2023-05-20.
Latest market close$12.06
52-week range$5.44 - $28.35
50-day moving average $14.13
200-day moving average $19.42
Wall St. target price$39.56
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.17

Buy Day One Biopharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Day One Biopharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Day One Biopharmaceuticals price performance over time

Historical closes compared with the close of $12.06 from 2023-05-25

1 week (2023-05-19) -9.73%
1 month (2023-04-27) -0.33%
3 months (2023-02-27) -34.24%
6 months (2022-11-25) -43.67%
1 year (2022-05-27) 110.84%
2 years (2021-05-27) -53.42%
3 years (2020-05-27) 4,724.00%
5 years (2018-05-23) N/A

Day One Biopharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -34.88%
Return on equity TTM -56.01%
Profit margin 0%
Book value $4.08
Market capitalisation $982.9 million

TTM: trailing 12 months

Day One Biopharmaceuticals share dividends

We're not expecting Day One Biopharmaceuticals to pay a dividend over the next 12 months.

Day One Biopharmaceuticals overview

Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California. .

Frequently asked questions

What percentage of Day One Biopharmaceuticals is owned by insiders or institutions?
Currently 29.284% of Day One Biopharmaceuticals shares are held by insiders and 82.303% by institutions.
How many people work for Day One Biopharmaceuticals?
Latest data suggests 125 work at Day One Biopharmaceuticals.
When does the fiscal year end for Day One Biopharmaceuticals?
Day One Biopharmaceuticals's fiscal year ends in December.
Where is Day One Biopharmaceuticals based?
Day One Biopharmaceuticals's address is: 395 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Day One Biopharmaceuticals's ISIN number?
Day One Biopharmaceuticals's international securities identification number is: US23954D1090

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site